Lonza (LONN.SW)

Lonza's price has climbed unusually fast and now sits roughly a fifth above its longer-term average.

What is going on right now?

The stock has been on a strong run, trading near the top of its recent range at 628. Streaks like this have often taken a breather, though the timing is never predictable.

How is the business itself doing?

Lonza makes ingredients and biological products for pharmaceutical companies, essentially a factory-for-hire. Revenue grew about 11% and earnings jumped nearly 40%, but the company actually spent more cash than it brought in recently.

What stands out?

Operating profits are healthy at around 23% of sales, yet overall profit after all costs dipped slightly negative. That gap hints at large one-time spending or investments.

What comes next?

Lonza's cash spending patterns over the next quarter will show whether those heavy outlays are winding down or continuing.